 |
|
The Use of Tetracyclines for the Treatment of Sarcoidosis
Hervé Bachelez, MD, PhD;
Patricia Senet, MD;
Jacques Cadranel, MD;
Alexandre Kaoukhov, MD;
Louis Dubertret, MD
Arch Dermatol. 2001;137:69-73.
Background To evaluate the safety and efficacy of minocycline in the treatment of sarcoidosis, a nonrandomized, open study was performed in patients with cutaneous sarcoidosis.
Observations Twelve patients with cutaneous sarcoidosis were treated with minocycline, 200 mg/d, for a median duration of 12 months. Three patients had extracutaneous lesions at the time of the study. The median follow-up was 26 months. A clinical response was observed in 10 patients, consisting of complete responses in 8 patients and partial responses in 2 patients. A progression of skin lesions was observed in 1 patient, and lesions remained stable in another patient. Adverse effects were minimal, except in 1 patient, who developed hypersensitivity syndrome. A slight hyperpigmentation occurred in 2 patients at the site of previous lesions, which completely disappeared after minocycline use was discontinued. A relapse of skin symptoms occurred after minocycline withdrawal in 3 patients, who further received doxycycline, 200 mg/d, allowing a complete remission of lesions.
Conclusions These results support that minocycline and doxycycline may be beneficial for the treatment of cutaneous sarcoidosis. Randomized controlled studies are warranted for the evaluation of the true efficacy of tetracyclines in these patients.
From the Institut de Recherche sur la Peau et Service de Dermatologie 1, Hôpital Saint-Louis (Drs Bachelez, Senet, Kaoukhov, and Dubertret), and the Service de Pneumologie, Hôpital Tenon (Dr Cadranel), Paris, France.
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2001;137(1):108.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Randomized Double-Blind Trial of Prophylactic Oral Minocycline and Topical Tazarotene for Cetuximab-Associated Acne-Like Eruption
Scope et al.
JCO 2007;25:5390-5396.
ABSTRACT
| FULL TEXT
Sarcoidosis
Iannuzzi et al.
NEJM 2007;357:2153-2165.
FULL TEXT
Minocycline for the Treatment of Ocular and Ocular Adnexal Sarcoidosis
Park et al.
Arch Ophthalmol 2007;125:705-709.
FULL TEXT
A 47-year-old woman with sarcoidosis.
Weinberger
JAMA 2006;296:2133-2140.
ABSTRACT
| FULL TEXT
Adalimumab for Treatment of Cutaneous Sarcoidosis
Heffernan and Smith
Arch Dermatol 2006;142:17-19.
FULL TEXT
Development of Sarcoidosis in Cosmetic Tattoos
Antonovich and Callen
Arch Dermatol 2005;141:869-872.
ABSTRACT
| FULL TEXT
Indigenous Pulmonary Propionibacterium acnes Primes the Host in the Development of Sarcoid-Like Pulmonary Granulomatosis in Mice
Nishiwaki et al.
Am. J. Pathol. 2004;165:631-639.
ABSTRACT
| FULL TEXT
Propionibacterium acnes: An Indigenous Bacterium May Be Pathogenic in Several Cutaneous Disease States
Burkhart and Burkhart
Arch Dermatol 2001;137:1250-1250.
FULL TEXT
The Presence of Foreign Bodies Does Not Exclude the Diagnosis of Sarcoidosis
Callen
Arch Dermatol 2001;137:485-486.
FULL TEXT
Minocycline or Doxycycline May Be Effective Treatment for Cutaneous Sarcoidosis
Journal Watch Dermatology 2001;2001:3-3.
FULL TEXT
|
